GLP-1 TV · Patient story · views checked Oct 2026
PeterMD First review on tirzepatide
Our summary
Amy, who says she has used PeterMD for tirzepatide since November 7th, 2024, shares her first review of the service. She lists three things she likes: it is a Christian organization that talks about Peter failing and returning to the path of following Christ, the price, and the customer service. She says emails get a reply within minutes at times, and that the staff are responsive and explain things well.
One person's experience, in their words. Not medical advice.
Where semaglutide costs least today
The three cheapest partner programs for semaglutide, all in per month, checked weekly. Brand Ozempic and compounded versions are different products; each row says which it is.
What else the video covers
She reports losing 10 pounds in two months and says she is very excited about it. She contrasts this with 2021, when she says she used Ozempic for a year and a half and her best month was a loss of 3 pounds, even while eating carefully and exercising four to five times a week with gym visits, hydrotherapy and weight lifting. She says she was very intentional about it.
Amy explains that she switched to tirzepatide after regaining weight once her insurance stopped paying for her earlier medication. She says she has many health concerns and is on disability, which limits her ability to get to the gym. According to her, the extra weight was making her symptoms worse. She would like to lose another 25 pounds to return to her earlier weight, and she says that after her previous loss she was more active, which made the weight easier to manage. She plans to keep using PeterMD and encourages others to do the same.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 0:03 Amy says she started tirzepatide through PeterMD on November 7th, 2024, and likes its Christian focus, price and customer service.
- 0:03 She says email replies from the service sometimes arrive within minutes and that staff explain things well.
- 0:36 She reports losing 10 pounds in two months, compared with a best month of 3 pounds on Ozempic in 2021.
- 0:36 She says she switched to tirzepatide after weight returned once her insurance stopped covering her earlier medication.
- 1:06 She says disability and health limits keep her from the gym, and added weight was worsening her symptoms.
- 1:06 She wants to lose 25 more pounds and plans to continue with PeterMD.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- tirzepatide
- Who is speaking
- Patient
Questions this video answers
How much weight did she lose on tirzepatide in two months?
Amy says she lost 10 pounds in two months after starting tirzepatide through PeterMD on November 7th, 2024. She says she would like to lose 25 more pounds.
How did tirzepatide results compare with Ozempic for this patient?
Amy says that in 2021 she used Ozempic for a year and a half, and her biggest monthly loss was 3 pounds, despite eating carefully and exercising four to five times a week. She reports a larger loss on tirzepatide.
Why did she switch to tirzepatide?
She says she regained weight after her insurance stopped paying for her earlier medication. She also says her health conditions and disability limit her gym access.
What does she say about PeterMD customer service?
Amy says the customer service has been excellent, with email replies sometimes arriving within minutes. She says the staff are responsive and explain things well.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
My Tirzepatide Journey - IVIM Health Honest ReviewBrittney, who posts as TBH by Brittney, shares a week-five update on compounded tirzepatide.
Starting Compounded Tirzepatide… for the 3rd Time (What I’m Doing Differently This Time in 2026)In this video, Heather says she is starting compounded tirzepatide, which she also calls compounded GLP-1 medication, for the third time.
First month on compounded tirzepatide #zepBound #mounjaro for Fast Weight Loss.In this video, a woman who introduces herself as Ebony (the channel is named Bianca) reports on her first month taking compounded tirzepatide.
Why Tirzepatide Was the BEST Weight Loss Decision I Ever Made 💉 | Real Results & What to ExpectIn this video, creator Roseland Lashay talks about her experience with tirzepatide, which she started on January 1, 2025 after deciding to change her diet at the start of the year.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Tirzepatide vs semaglutide: the head-to-head result, and what the better one costs
They were finally tested against each other. In SURMOUNT-5, 751 adults with obesity took the maximum tolerated dose of one or the other for 72 weeks: tirzepatide lost 20.2% of body weight, semaglutide 13.7%. That gap is real and it is the whole argument for tirzepatide. The other half of the decision is the bill: compounded tirzepatide runs from $85 a month on our board against $69 for semaglutide, and the branded gap is wider still.
- Retatrutide: up to 28.3% weight loss in trials, no FDA approval yet, and no legal way to buy it today
Retatrutide is Eli Lilly's experimental weekly injection that acts on three hormone receptors (GIP, GLP-1 and glucagon). In the phase 3 TRIUMPH-1 trial, people on the 12 mg dose lost 28.3% of their weight at 80 weeks by Lilly's efficacy measure (25.0% counting everyone randomized). It is not FDA-approved, has no price, and cannot legally be sold. Lilly plans to file with FDA in Q1 2027. Tirzepatide is the closest thing you can buy now, compounded from $85 a month on our board.
- What is Zepbound? Tirzepatide explained: what it treats, how it works, and what it costs
Zepbound is Eli Lilly's brand of tirzepatide, a once-weekly injection that acts on two hormone receptors, GIP and GLP-1. The FDA label approves it, with diet and exercise, for weight reduction in adults with obesity or overweight plus a weight-related condition, and for moderate to severe obstructive sleep apnea in adults with obesity. In the SURMOUNT-5 trial it produced 20.2% average weight loss at 72 weeks against 13.7% for semaglutide. Lilly sells it self-pay from $299 a month.
Find more like it
Weigh-in and resultsExercise and strength
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.